Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer

被引:99
作者
Hachey, Krista J. [1 ]
Hewes, Philip D. [2 ]
Porter, Liam P. [2 ]
Ridyard, Douglas G. [2 ]
Rosenkranz, Pamela [1 ]
McAneny, David [1 ]
Fernando, Hiran C. [3 ]
Litle, Virginia R. [3 ]
机构
[1] Boston Univ, Dept Surg, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Div Thorac Surg, Boston, MA 02118 USA
基金
美国国家卫生研究院;
关键词
lung cancer; postoperative care; embolism (venous); HIP-ARTHROPLASTY; EXTENDED DURATION; ENOXAPARIN; SURGERY; COMPLICATIONS; RIVAROXABAN; PREVENTION; MANAGEMENT; CARE; THROMBOPROPHYLAXIS;
D O I
10.1016/j.jtcvs.2015.08.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Postoperative venous thromboembolism (VTE) creates an 8-fold increase in mortality after lung resection. About one third of postoperative VTEs occur after discharge. The Caprini risk assessment model has been used by other specialties to calculate the risk of a VTE. Patients deemed high risk by the model are candidates for prophylactic anticoagulation after discharge, reducing the VTE risk by 60%. Our primary aims were to determine the frequency of VTE events and evaluate whether the Caprini model could risk-stratify patients. Methods: Patients undergoing lung cancer resections during 2005 to 2013 were evaluated. Exclusion criteria were preoperative filter and therapeutic anticoagulation. A total of 232 patients were reviewed and Caprini scores calculated. Subjects were risk stratified into groups of low risk (0-4), moderate risk (5-8), and high risk (>= 9). Occurrence of VTE events (deep vein thrombosis; pulmonary embolism) were identified by imaging. Results: The 60-day VTE incidence was 5.2%(12 of 232); 33.3% occurred post-discharge (n = 4). Half (6 of 12) were pulmonary emboli, 1 of which caused a death, in an inpatient with a score of 16. The VTE incidence increased with Caprini score. Scores in the low, moderate, and high risk groups were associated with a VTE incidence of 0%, 1.7%, and 10.3%, respectively. With a high risk score cutoff of 9, the sensitivity, specificity, and accuracy are 83.3%, 60.5%, and 61.6%, respectively. Conclusions: One third of VTE events occurred after discharge. Postoperative VTE incidence was correlated with increasing Caprini scores. Patients in the high risk group had an incidence of 10.3%. Elevated scores may warrant extended chemoprophylaxis for patients after discharge.
引用
收藏
页码:37 / +
页数:9
相关论文
共 27 条
[1]   A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method [J].
Bahl, Vinita ;
Hu, Hsou Mei ;
Henke, Peter K. ;
Wakefield, Thomas W. ;
Campbell, Darrell A., Jr. ;
Caprini, Joseph A. .
ANNALS OF SURGERY, 2010, 251 (02) :344-350
[2]   Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. [J].
Bergqvist, D ;
Agnelli, G ;
Cohen, AT ;
Eldor, A ;
Nilsson, PE ;
Le Moigne-Amrani, A ;
Dietrich-Neto, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) :975-980
[3]   Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity [J].
Borkgren-Okonek, Marilyn J. ;
Hart, Robert W. ;
Pantano, John E. ;
Rantis, Peter C., Jr. ;
Guske, Paul J. ;
Kane, James M., Jr. ;
Gordon, Nancy ;
Sambol, Nancy C. .
SURGERY FOR OBESITY AND RELATED DISEASES, 2008, 4 (05) :625-631
[4]   Reducing Postoperative Venous Thromboembolism Complications with a Standardized Risk-Stratified Prophylaxis Protocol and Mobilization Program [J].
Cassidy, Michael R. ;
Rosenkranz, Pamela ;
McAneny, David .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 218 (06) :1095-1104
[5]  
Connolly GC, 2013, CLIN LUNG CANCER, V14, P713, DOI [10.1016/j.cllc.2013.06.003, 10.1016/j.dlc.2013.06.003]
[6]   Variation in thromboembolic complications among patients undergoing commonly performed cancer operations [J].
De Martino, Randall R. ;
Goodney, Philip P. ;
Spangler, Emily L. ;
Wallaert, Jessica B. ;
Corriere, Matthew A. ;
Rzucidlo, Eva M. ;
Walsh, Daniel B. ;
Stone, David H. .
JOURNAL OF VASCULAR SURGERY, 2012, 55 (04) :1035-1041
[7]   Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a US payer's perspective [J].
Aurea Duran ;
Nishan Sengupta ;
Alexander Diamantopoulos ;
Fiona Forster ;
Louis Kwong ;
Michael Lees .
PharmacoEconomics, 2012, 30 (2) :87-101
[8]   Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty [J].
Eriksson, Bengt I. ;
Borris, Lars C. ;
Friedman, Richard J. ;
Haas, Sylvia ;
Huisman, Menno V. ;
Kakkar, Ajay K. ;
Bandel, Tiemo J. ;
Beckmann, Horst ;
Muehlhofer, Eva ;
Misselwitz, Frank ;
Geerts, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26) :2765-2775
[9]   Care of patients undergoing vascular surgery at safety net public hospitals is associated with higher cost but similar mortality to nonsafety net hospitals [J].
Eslami, Mohammad H. ;
Rybin, Denis ;
Doros, Gheorghe ;
Farber, Alik .
JOURNAL OF VASCULAR SURGERY, 2014, 60 (06) :1627-1634
[10]   Prevention of VTE in Nonorthopedic Surgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].
Gould, Michael K. ;
Garcia, David A. ;
Wren, Sherry M. ;
Karanicolas, Paul J. ;
Arcelus, Juan I. ;
Heit, John A. ;
Samama, Charles M. .
CHEST, 2012, 141 (02) :E227S-E277S